New drug cocktail shows promise for Hard-to-Treat myeloma
NCT ID NCT01665794
First seen Jan 07, 2026 · Last updated May 15, 2026 · Updated 25 times
Summary
This study tested a combination of three drugs (pomalidomide, dexamethasone, and carfilzomib) in 25 people whose multiple myeloma had returned or stopped responding to prior treatments. The goal was to find the safest dose and see how well the drugs worked together. Results helped guide further research on adding a fourth drug, daratumumab.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MULTIPLE MYELOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Sarah Cannon Research Institute
Nashville, Tennessee, 37203, United States
-
University Health Network - Princess Margaret Cancer Center
Toronto, Ontario, MISG 2M9, Canada
-
University of Chicago Comprehensive Cancer Center
Chicago, Illinois, 60637-1470, United States
-
University of Michigan Comprehensive Cancer Center
Ann Arbor, Michigan, 48109, United States
-
Wayne State University - Karmonos Cancer Center
Detroit, Michigan, 48201, United States
Conditions
Explore the condition pages connected to this study.